CATALINA LEHRER: Open Payments
NPI 1508978396 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,014 in 92 payments from 15 companies in 2025. Trend: 2023 $1,682 · 2024 $2,258 · 2025 $2,014
Food & beverage: $2,014
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $379 |
| PFIZER INC. | 12 | $314 |
| Janssen Biotech, Inc. | 15 | $283 |
| Novartis Pharmaceuticals Corporation | 13 | $196 |
| Incyte Corporation | 5 | $140 |
| UCB, Inc. | 5 | $130 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $101 |
| Organon LLC | 6 | $85 |
| Galderma Laboratories, L.P. | 4 | $74 |
Products named: CIBINQO, TREMFYA, RINVOQ, DUPIXENT, COSENTYX, OPZELURA, Bimzelx, SKYRIZI.
Industry payments across MD — which companies pay providers there.
